树突状细胞为基础的肿瘤生物免疫治疗
Biological Immunotherapy on Cancers based on Dendritic Cells
出处
《中国慢性病预防与控制》
CAS
2005年第2期94-95,共2页
Chinese Journal of Prevention and Control of Chronic Diseases
参考文献14
-
1Trate K,Klein B.Dendritic cell-based vaccine:A promising approach for cancer immunotheerafy[J]. Leukemia, 1999,13:653-663.
-
2Sallusto F.Dendritic cells use macropinocy tosiss and the mannose receptor to concentrate macromolecules in the MHC Ⅱ compartment:downregulation by cytokines and bacterial products [J]. J Exp Med,1995,182:389-400.
-
3Ridge JP.A conditional dendritic cell can be a temporal bridge between a CD4+T-helper and a T-killer cell [ J ]. Nature,1998,393:474-478.
-
4Di Nicola M,Anichini A,Mortarini R,et al. Human dendritic cells:natural adjuvants in antitumor immunotherafy [J].Cytokine Cell Mol Ther ,1998,4:273.
-
5Young JW,Inaba K.Dendritic cells as adjuvants for class Ⅰ major histocompatibility compler-restricted antitumor immunity [J]. J Exp Med , 1996,183:11.
-
6Timmerman J M, Levy R. Dendritic cell vaccines for cancer immunotherapy [J]. Ann Rev Med, 2004,50:507-529.
-
7Ebner S,Ratzinger G,Krosbacher B,et al. Production of IL-12 by human moncyte-derived debdritic cells is optimal when the stimulus is given at the onset of maturation abd is further enhanced by IL-4 [J]. J Immunol,2001,166:633-641.
-
8Wan Y, Emtage P, Zhu Q, et al. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells[J]. Cell Immunol, 1999 , 198:131-138.
-
9Chiriva-Internati M, Liu Y, Salati E, et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adenoassociated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells[J]. Eur J Immunol, 2002,32:30-38.
-
10Miller PW, Sharma S, Stolina M ,et al. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication [J]. Hum Gene Ther, 2000,11:53-65.
-
1任鹏涛,张苑,蔡建辉,张艳,田青.特异性抗原致敏的DC-CIK与DC-CTL细胞对黑色素瘤抑瘤作用的比较[J].天津医科大学学报,2011,17(2):173-176. 被引量：2
-
2崔荣花,彭大为.KAI1/CD_(82)与消化道肿瘤的研究进展[J].医学综述,2014,20(3):440-442.
-
3石光清,曹艳.Survivin蛋白和BRAF基因在甲状腺癌中的表达[J].中国现代医学杂志,2012,22(19):61-66. 被引量：7
-
4许晨,赵文川.甲状腺癌分子标记物研究进展[J].现代肿瘤医学,2006,14(3):357-360. 被引量：3
-
5罗业琳.树突状细胞在妇科肿瘤免疫治疗中的研究进展[J].医学综述,2008,14(21):3252-3254.
-
6栾明春,刘颖丽,侯君,马克里.抑癌基因KAI1/CD82调控机制研究进展[J].医学动物防制,2017,33(2):169-170. 被引量：1
-
7任鹏涛,张苑,阎庆辉,张国建,林林.特异性抗原致敏的DC-CIK细胞对B16黑色素瘤多途径抑瘤作用的研究[J].河北医药,2012,34(20):3057-3060. 被引量：3
-
8吕丽琼,刘剑勇.树突状细胞与乳腺癌的最新研究进展[J].医学综述,2007,13(14):1054-1056. 被引量：1
-
9纪祥军,王汉东.靶向调节胶质母细胞瘤血管生成的治疗进展[J].中华神经外科疾病研究杂志,2015,14(2):185-187.
-
10王崇国,王云,张江灵,张希成.特异性肿瘤细胞毒T淋巴细胞联合肝动脉插管化疗治疗晚期肝细胞癌前瞻性研究[J].实用肝脏病杂志,1998,3(2):65-66.
